The global event will bring together health ministers from more than 50 countries, the Director-General of the World Health Organization (WHO) and patient safety experts.
OMICS has come under attack by numerous academics and the United States government over the validity of the peer review by OMICS journals, the appropriateness of its fees and marketing, and the apparent advertising of the names of scientists as journal editors or conference speakers without their knowledge or permission. The U.S. National Institutes of Health sent a cease-and-desist letter to OMICS in 2013, demanding it to discontinue with false claims of affiliation with U.S. government entities or employees. In August 2016 OMICS became the first academic publisher to be sued by the U.S. Federal Trade Commission (FTC) for deceptive practices; nearly three years later, the FTC was awarded a summary judgement of over US$50 million. OMICS has responded to criticisms by avowing a commitment to open access publishing, claiming that detractors are traditional subscription-based publishers who feel threatened by their open access publishing model. It responded to the FTC suit by maintaining that their practices were legal and claiming that corporate interests were driving the suit. It has also threatened a prominent critic, Jeffrey Beall, with a $1 billion lawsuit for defamation